Knowledge gained from our study suggests that the combination of SU11274 and radiotherapy represents a promising regimen to improve the efficacy of conventional radiotherapy by inhibiting c-Met–mediated cancer cell aggressiveness. This evidence concerns the gene MET and cancer.